ENGN — enGene Holdings Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareSpeculativeMid CapNeutral

Annual balance sheet for enGene Holdings, fiscal year end - October 31st, millions except per share.

	2020 October 31st	2021 October 31st	2022 October 31st	2023 October 31st	2024 October 31st
Period Length:	—	—	—	—	—
Source:		PROSPECTUS	PROSPECTUS	10-K	10-K
Standards:	—	USG	USG	USG	USG
Status:	fx Preliminary	Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	—	11	20.4	81.5	238
Net Total Receivables	—	1.62	1.34	2.34	0.332
Prepaid Expenses
Total Other Current Assets
Total Current Assets	—	13.5	22.6	85.4	247
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	—	0.571	0.387	0.589	2.91
Long Term Investments
Other Long Term Assets
Total Assets	—	15	23.9	87	311
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	—	3.22	5.1	5.26	14.7
Long Term Debt
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities	—	15.4	47.4	14.5	38.6
Non Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	—	-0.324	-23.5	72.5	273
Total Liabilities & Shareholders' Equity	—	15	23.9	87	311
Total Common Shares Outstanding